Literature DB >> 19870124

IMMUNITY REACTIONS OF HUMAN SUBJECTS TO STRAINS OF PNEUMOCOCCI OTHER THAN TYPES I, II AND III.

M Finland1, W D Sutliff.   

Abstract

1. A group of 72 human subjects were studied with respect to the immune reactions of their blood and sera to Types I, II and III pneumococci and to 4 other types (V, VI, VIII and IX) previously included in Group IV. 2. The same general relationships were observed for all of these types as were previously demonstrated for Types I, II and III. Each type was specific in relation to the bactericidal action of normal human blood and the protective action of normal human serum. 3. The frequency with which pneumococcidal action for any pair of types was present for both or absent for both in the same blood samples was slightly greater than that calculated from the frequencies with which each of the types was killed separately. 4. No closer correlation could be demonstrated between the reaction of the blood of these subjects to Types II and V or between Types III and VIII pneumococci, types related in their reaction with artificially prepared immune sera, than was observed between unrelated strains.

Entities:  

Year:  1933        PMID: 19870124      PMCID: PMC2132212          DOI: 10.1084/jem.57.1.95

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

Authors:  W D Sutliff; M Finland
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

2.  THE SEPARATION OF TYPES AMONG THE PNEUMOCOCCI HITHERTO CALLED GROUP IV AND THE DEVELOPMENT OF THERAPEUTIC ANTISERUMS FOR THESE TYPES.

Authors:  G Cooper; M Edwards; C Rosenstein
Journal:  J Exp Med       Date:  1929-02-28       Impact factor: 14.307

3.  A FURTHER STUDY ON THE BIOLOGIC CLASSIFICATION OF PNEUMOCOCCI.

Authors:  O T Avery
Journal:  J Exp Med       Date:  1915-12-01       Impact factor: 14.307

4.  THE EPIDEMIOLOGY OF PNEUMOCOCCUS INFECTION : THE INCIDENCE AND SPREAD OF PNEUMOCOCCI IN THE NASAL PASSAGES AND THROATS OF HEALTHY PERSONS.

Authors:  L T Webster; T P Hughes
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

5.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VII. THE RELATION OF OPSONINS TO NATURAL RESISTANCE AGAINST PNEUMOCOCCUS INFECTION.

Authors:  O H Robertson; R H Sia
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

6.  A STUDY OF THE RESISTANCE OF NORMAL HUMAN BEINGS TO RECENTLY ISOLATED STRAINS OF PATHOGENIC PNEUMOCOCCI.

Authors:  O H Robertson; M A Cornwell
Journal:  J Exp Med       Date:  1930-07-31       Impact factor: 14.307

7.  SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307

8.  STUDIES ON IMMUNOLOGICAL RELATIONSHIPS AMONG THE PNEUMOCOCCI : I. A VIRULENT STRAIN OF PNEUMOCOCCUS WHICH Is IMMUNOLOGICALLY RELATED TO, BUT NOT IDENTICAL WITH TYPICAL STRAINS OF TYPE III PNEUMOCOCCI.

Authors:  J Y Sugg; E L Gaspari; W L Fleming; J M Neill
Journal:  J Exp Med       Date:  1928-05-31       Impact factor: 14.307

9.  OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD : I. THE NORMAL PHAGOCYTIC TITRE, AND THE ANTI-PHAGOCYTIC EFFECT OF THE SPECIFIC SOLUBLE SUBSTANCE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1930-04-30       Impact factor: 14.307

10.  THE FURTHER SEPARATION OF TYPES AMONG THE PNEUMOCOCCI HITHERTO INCLUDED IN GROUP IV AND THE DEVELOPMENT OF THERAPEUTIC ANTISERA FOR THESE TYPES.

Authors:  G Cooper; C Rosenstein; A Walter; L Peizer
Journal:  J Exp Med       Date:  1932-03-31       Impact factor: 14.307

  10 in total
  1 in total

1.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : III. FACTORS INFLUENCING THE PHAGOCYTOSIS OF PNEUMOCOCCI IN THE LUNG DURING SULFONAMIDE THERAPY.

Authors:  W B Wood; C McLeod; E N Irons
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.